Relation Between Serum IGF-1 & BMI In Acne Vulgaris

Assiut University90 enrolled

Overview

cross-sectional study in which participants will be recruited at dermatology \& Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists \& obtaining an informed consent

Study Type

OBSERVATIONAL

Enrollment

Conditions

Evaluation of Serum Level of Insulin Like Growth Factor 1

Eligibility

Sex: ALLMin age: 15 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients aged from 15 to 45 years old suffering from acne vulgaris. 2. Both sexes. Exclusion Criteria: 1. Insulin resistance and diabetic patients 2. Females with polycystic ovarian syndrome 3. Treatment with drugs that can influence IGF-1level such as corticosteroid, insulin, hypoglycemic agents, and isotretinoin within one year before the date of study. 4. Other causes of acne or acneform eruption as steroid-induced

Locations (1)

Rania Sallam

Cairo, Qalubya, Egypt

RECRUITING

Outcomes

Primary Outcomes

Evaluation of serum level of insulin like growth factor 1 in acne vulgaris

using the Chemiluminescent Microparticle Immunoassay

Time frame: 1 year

Central Contacts

Rania Sallam

CONTACT

113567939 Raniamohamed0887@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.